liberDi

LiberDi, Ltd. was founded in 2016 and is an innovative medical company invested in and incubated by Trendlines Group, Israel's leading incubator. LiberDi has independently developed a portable automatic dialysis system that provides efficient, convenient, and low-cost dialysis solutions for patients with end-stage renal disease (ESRD). The company’s Digital Dialysis Clinic has received regulatory approval from the U.S. Food and Drug Administration (FDA), allowing patients to perform dialysis at home or in the workplace while being monitored by doctors using the system’s advanced telemedicine capabilities.